Science & Enterprise subscription

Follow us on Twitter

  • An engineering group found a way to adapt a CPAP machine into a mechanical ventilator, a device for people needing… https://t.co/tJcdzaLspJ
    about 18 hours ago
  • New post on Science and Enterprise: Univ. Engineers Convert CPAP into Ventilator https://t.co/atwZ62PHU0 #Science #Business
    about 18 hours ago
  • A biotechnology company specializing in infectious diseases is developing a vaccine to protect against Covid-19 inf… https://t.co/RT5znygGYm
    about 24 hours ago
  • New post on Science and Enterprise: Covid-19 Vaccine in Development, Trial Planned https://t.co/CxTssHGlFw #Science #Business
    about 24 hours ago
  • A group of Canadian academic labs and hospitals will begin a clinical trial testing antibodies from recovered Covid… https://t.co/BsfaYEhTGM
    about 2 days ago

Please share Science & Enterprise

Covid-19 Vaccine in Development, Trial Planned

Coronavirus graphic

A biotechnology company specializing in infectious diseases is developing a vaccine to protect against Covid-19 infections, with a clinical trial to start next month. . . . → Read More: Covid-19 Vaccine in Development, Trial Planned

Biotechs Explore Cell Therapy for Covid-19 Antibodies

Coronavirus face mask

Two biotechnology companies are researching use of a non-viral gene therapy to deliver synthetic antibodies for treating Covid-19 infections. . . . → Read More: Biotechs Explore Cell Therapy for Covid-19 Antibodies

Commentary – Biotech, Trump’s Latest Casino

SARS-Cov-2 virus

If you thought the Trump administration couldn’t bungle any worse its response to the coronavirus pandemic, think again. . . . → Read More: Commentary – Biotech, Trump’s Latest Casino

Contact Lens Material Reduces Color Blindness

Red-blue-green eye

An engineered ultra-thin material designed for contact lenses is shown in lab tests to help correct for a common form of color blindness. . . . → Read More: Contact Lens Material Reduces Color Blindness

Proteins from Bacteria Generate Power for Wearables

Air-gen device

A collaboration of engineers and biologists created a way of producing electric power from humidity in the air with fine wires made of proteins from bacteria. . . . → Read More: Proteins from Bacteria Generate Power for Wearables

Engineered Bacteria Deliver Cancer Immunotherapy

E. coli

Escherichia coli, or E. coli, bacteria (National Institute of Allergy and Infectious Diseases)

13 Feb. 2020. A biomedical engineering team designed probiotic bacteria, which in lab mice are shown to deliver and enhance cancer immunotherapy drugs. Researchers at Columbia University in New York describe their engineered bacteria and findings in yesterday’s issue of . . . → Read More: Engineered Bacteria Deliver Cancer Immunotherapy

Synthetic Cell Matrix Devised for Cancer Drug Testing

Honeycomb scaffold

A bioengineering lab is creating synthetic cell scaffolds that simulate tumor cells and tissue, offering a more reliable way of testing new cancer drugs. . . . → Read More: Synthetic Cell Matrix Devised for Cancer Drug Testing

Synthetic DNA Studied for Mass Data Storage

DNA illustration

An industry-academic consortium received a U.S. government contract to develop coded synthetic polymer chemicals like DNA for reliably storing massive amounts of data. . . . → Read More: Synthetic DNA Studied for Mass Data Storage

Light-Activated Brain Electrodes in Development

brain stimulationgraphic

A wireless electrode activated by light waves is being developed to connect with nerve cells in the brain that promises to make brain-computer connections safer. . . . → Read More: Light-Activated Brain Electrodes in Development

Vaccine Developer Gains $11M in Early Funds

Baby with microcephaly

A company designing vaccines delivered with a microneedle patch to prevent infectious diseases is raising $11 million in its first venture funding round. . . . → Read More: Vaccine Developer Gains $11M in Early Funds